Atomic basis for therapeutic activation of neuronal potassium channels

Nature Communications
Robin Y KimHarley T Kurata

Abstract

Retigabine is a recently approved anticonvulsant that acts by potentiating neuronal M-current generated by KCNQ2-5 channels, interacting with a conserved Trp residue in the channel pore domain. Using unnatural amino-acid mutagenesis, we subtly altered the properties of this Trp to reveal specific chemical interactions required for retigabine action. Introduction of a non-natural isosteric H-bond-deficient Trp analogue abolishes channel potentiation, indicating that retigabine effects rely strongly on formation of a H-bond with the conserved pore Trp. Supporting this model, substitution with fluorinated Trp analogues, with increased H-bonding propensity, strengthens retigabine potency. In addition, potency of numerous retigabine analogues correlates with the negative electrostatic surface potential of a carbonyl/carbamate oxygen atom present in most KCNQ activators. These findings functionally pinpoint an atomic-scale interaction essential for effects of retigabine and provide stringent constraints that may guide rational improvement of the emerging drug class of KCNQ channel activators.

References

Jan 1, 1987·Annals of the New York Academy of Sciences·C J Deutsch, J S Taylor
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·J P Gallivan, D A Dougherty
Jul 25, 2000·Molecular Pharmacology·M J MainS A Burbidge
Aug 23, 2000·Molecular Pharmacology·A D WickendenP K Wagoner
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·J S MitchesonM C Sanguinetti
Feb 13, 2001·British Journal of Pharmacology·A D WickendenT Jegla
Oct 3, 2002·The Journal of Physiology·M M ShahP Delmas
Jul 10, 2003·Current Opinion in Neurobiology·Darren L BeeneHenry A Lester
May 14, 2004·Journal of Medicinal Chemistry·Yong-Jin WuSteven I Dworetzky
Feb 22, 2005·Current Medicinal Chemistry·Yong-Jin Wua, Steven I Dworetzky
May 4, 2005·CNS Drug Reviews·G Blackburn-MunroR E Blackburn-Munro
May 20, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anne SchenzerMichael Schwake
May 20, 2005·Nature·Yoshimichi MurataYasushi Okamura
Aug 15, 2006·Neuropharmacology·Bo Hjorth BentzenSøren-Peter Olesen
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Roger J PorterChris Rundfeldt
Dec 7, 2007·Current Opinion in Pharmacology·Francesco MiceliMaurizio Taglialatela
Jan 22, 2008·Trends in Pharmacological Sciences·Qiaojie XiongMin Li
May 16, 2009·Pharmacological Reports : PR·Jarogniew J Luszczki
Jul 6, 2010·Cleveland Clinic Journal of Medicine·Sandipan Pati, Andreas V Alexopoulos
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Asher PeretzBernard Attali
Oct 15, 2010·Neurology·M J BrodieUNKNOWN RESTORE 2 Study Group
Nov 16, 2010·Seizure : the Journal of the British Epilepsy Association·Martin J Brodie
Jun 16, 2011·Nature Communications·Stephan A PlessChristopher A Ahern
Jun 22, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Nathalie Strutz-SeebohmGuiscard Seebohm
Jul 13, 2012·Expert Opinion on Pharmacotherapy·Gökce OrhanHolger Lerche
Aug 21, 2012·Seizure : the Journal of the British Epilepsy Association·Marrissa Martyn-St JamesPeter W Lane
Nov 28, 2012·British Journal of Pharmacology·A BoehlenC Gebhardt
Nov 28, 2012·The Journal of General Physiology·Jérôme J LacroixFrancisco Bezanilla
Dec 12, 2012·Trends in Neurosciences·Andrew Lutas, Gary Yellen
May 9, 2013·Nature Communications·Stephan A PlessChristopher A Ahern
May 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Shuang LiThanos Tzounopoulos
Aug 9, 2013·Epilepsia·Karen S WilcoxMichael A Rogawski

❮ Previous
Next ❯

Citations

Feb 18, 2016·The Journal of General Physiology·Aaron Corbin-LeftwichCarlos A Villalba-Galea
Aug 11, 2016·The Journal of Physiology·Alice W WangHarley T Kurata
Oct 22, 2016·Channels·Carlos A Villalba-Galea
Nov 3, 2016·ELife·John D LueckChristopher A Ahern
Feb 2, 2017·The Journal of Physiology·Rene Barro-SoriaH Peter Larsson
Oct 14, 2016·Scientific Reports·Jeroen I StasDirk J Snyders
Mar 28, 2018·Scientific Reports·Daniel T InfieldChristopher A Ahern
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Robin Y KimHarley T Kurata
Oct 31, 2018·The Journal of General Physiology·Caroline K WangHarley T Kurata
Apr 17, 2019·Organic & Biomolecular Chemistry·Abdrrahman S SururAndreas Link
May 12, 2018·Nature Communications·Rían W ManvilleGeoffrey W Abbott
Jul 20, 2018·Molecular Pharmacology·Rían W Manville, Geoffrey W Abbott
Sep 23, 2018·Nature Communications·Rían W Manville, Geoffrey W Abbott
Oct 2, 2019·Proceedings of the National Academy of Sciences of the United States of America·Rían W ManvilleGeoffrey W Abbott
Nov 24, 2019·The Journal of Pharmacology and Experimental Therapeutics·Rían W ManvilleGeoffrey W Abbott
May 5, 2020·The Journal of General Physiology·Johan E LarssonSara I Liin
Mar 29, 2020·The Journal of Pharmacology and Experimental Therapeutics·Rían W Manville, Geoffrey W Abbott
Jul 18, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rían W Manville, Geoffrey W Abbott
Jul 12, 2020·Epilepsia·Richard KanyoHarley T Kurata
Jun 3, 2020·The Journal of General Physiology·Harley T Kurata
Jul 28, 2020·The Journal of Physiology·N BraunS A Pless
Sep 1, 2018·The Journal of General Physiology·Alice W WangHarley T Kurata
Sep 1, 2018·The Journal of General Physiology·Michael C YauHarley T Kurata
Feb 26, 2019·Future Medicinal Chemistry·Christian Bock, Andreas Link
Oct 22, 2019·Assay and Drug Development Technologies·Benjamin WilenkinBirgit T Priest
Jun 6, 2020·Frontiers in Pharmacology·Kenny M Van TheemscheAlain J Labro
Mar 24, 2016·Molecular Pharmacology·Manoj KumarThanos Tzounopoulos
Jul 18, 2020·Frontiers in Physiology·Gema Mondejar-ParreñoAngel Cogolludo
Dec 12, 2019·Frontiers in Physiology·Aguan D Wei, Jan-Marino Ramirez
Jul 9, 2020·Frontiers in Pharmacology·Carlos A Villalba-Galea
Mar 15, 2020·The Journal of Membrane Biology·Sai ShiHailong An
Jul 10, 2020·Communications Biology·Kaitlyn E Redford, Geoffrey W Abbott
Nov 26, 2020·Molecular Cell·Tian LiHuaizong Shen
Dec 17, 2020·International Journal of Molecular Sciences·Xiaoan Wu, H Peter Larsson
Jan 8, 2021·Arhiv za higijenu rada i toksikologiju·Ana Matošević, Anita Bosak
May 29, 2021·RSC Medicinal Chemistry·Matteo BorginiPeter Wipf
Jun 27, 2021·European Journal of Pharmacology·Moawiah M Naffaa, Ola A Al-Ewaidat
Oct 20, 2020·ACS Pharmacology & Translational Science·Nihar KinarivalaPaul C Trippier
Oct 16, 2021·Communications Biology·Shashank PantEmad Tajkhorshid

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

YASARA Structure
pClamp
AMBER03

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Kohei Sawada
© 2021 Meta ULC. All rights reserved